Characteristics of accountable care organizations offering methadone to patients with opioid use disorder.

ABSTRACT: Understanding whether organizations with Medicare and Medicaid accountable care organization (ACO) contracts offer methadone provides important context about how organizations invested in payment and delivery system reform address the needs of patients with substance use disorders. We used data from the 2021-2022 National Survey of Accountable Care Organizations to assess whether organizations with ACO contracts, which are held accountable for the cost and quality of care for an assigned patient population, offered methadone to patients with opioid use disorder (OUD), and the organizational and contextual characteristics associated with doing so. We found that 28.3% of survey respondents reported that clinicians in their organizations offered methadone via an opioid treatment program. In a

SUBMITTER: Crawford M 

PROVIDER: S-EPMC12015604 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature